• Users Online: 317
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2014  |  Volume : 8  |  Issue : 5  |  Page : 10-13

Nephrology and kidney transplantation in India: Past, present and future


Professor and Director, Department of Nephrology, Transplantation Medicine and Immunology, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre [IKDRC], Dr. H.L. Trivedi Institute of Transplantation Sciences, Civil Hospital Campus, Asarwa, Ahmedabad 380016, Gujarat, India

Correspondence Address:
H L Trivedi
Professor and Director, Department of Nephrology, Transplantation Medicine and Immunology, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre [IKDRC], Dr. H.L. Trivedi Institute of Transplantation Sciences, Civil Hospital Campus, Asarwa, Ahmedabad 380016, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.1016/j.ijt.2014.01.006

Get Permissions

Chronic kidney disease (CKD) has been recognized as a major global public health problem. The approximate prevalence of CKD in India is 800 per million populations (pmp). Kidney transplantation is considered as the best therapeutic modality for patients suffering from end stage renal disease (ESRD). Transplantation started in 1953 in Europe and USA and in India it started in 1965. The awareness of deceased donor organ transplants, cross-over transplants and other organs like liver and heart is also gradually increasing with Tamil nadu leading the country in deceased donor organ transplants. The alternative to post-transplant immunosuppression and associated problems is ‘transplant tolerance’ which means stable graft function with no immunosuppression while keeping immune system of the host intact. We at Ahmedabad have pioneered the technique of in vitro generation of human adipose tissue-derived mesenchymal stem cells (AD-MSC) and T-regulatory cells. Once again we have pioneered (in the world) the infusion of these cells along with hematopoietic stem cells in renal allograft recipients. Abrogation of antibodies using Bortezomib again established by our group in Ahmedabad which is now universally being adapted has improved renal transplant outcomes. This review briefly takes the reader to evolution of nephrology and kidney transplantation in India and shows that we have bright future!


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed818    
    Printed19    
    Emailed0    
    PDF Downloaded78    
    Comments [Add]    

Recommend this journal